JASPER THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Amount
JASPER THERAPEUTICS, INC. (JSPR) reported Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Amount of -$2.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxSettlementsStateAndLocal · last filed 2026-03-30
- JASPER THERAPEUTICS, INC. effective income tax rate reconciliation, tax settlement, state and local, amount for fiscal 2024 was -$2.00K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Amount 12 month |
|---|---|
| 2024-12-31 | -$2.00K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |